We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$3.9B
AUM Growth
+$252M
Cap. Flow
+$73.2M
Cap. Flow %
1.88%
Top 10 Hldgs %
29.07%
Holding
576
New
42
Increased
208
Reduced
140
Closed
20

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$8.42M
2
TMO icon
Thermo Fisher Scientific
TMO
+$3.09M
3
AAPL icon
Apple
AAPL
+$2.88M
4
ASML icon
ASML
ASML
+$2.49M
5
TIF
Tiffany & Co.
TIF
+$2.36M

Sector Composition

Rank Sector Weight
1 Technology 19.5%
2 Healthcare 14.83%
3 Financials 12.72%
4 Communication Services 8.9%
5 Consumer Staples 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDP icon
226
COPT Defense Properties
CDP
$4.3B
$857K 0.02%
32,560
-450
-1% -$11.9K
IBMJ
227
DELISTED
iShares iBonds Dec 2021 Term Muni Bond ETF
IBMJ
$850K 0.02%
33,050
-2,000
-6% -$51.5K
DXJ icon
228
WisdomTree Japan Hedged Equity Fund
DXJ
$7.08B
$834K 0.02%
13,600
-20,300
-60% -$1.18M
XYZ
229
Block Inc
XYZ
$48.4B
$830K 0.02%
3,655
+300
+9% +$70.2K
OLED icon
230
Universal Display
OLED
$3.68B
$829K 0.02%
3,500
VTR icon
231
Ventas
VTR
$48B
$821K 0.02%
15,384
-2,284
-13% -$117K
VIG icon
232
Vanguard Dividend Appreciation ETF
VIG
$111B
$819K 0.02%
5,567
-74
-1% -$10.5K
ELV icon
233
Elevance Health
ELV
$81.5B
$812K 0.02%
2,262
-56
-2% -$18K
MIDD icon
234
Middleby
MIDD
$6.04B
$802K 0.02%
4,841
+280
+6% +$41.2K
KHC icon
235
Kraft Heinz
KHC
$30.7B
$789K 0.02%
19,735
-8,816
-31% -$318K
CAH icon
236
Cardinal Health
CAH
$53.9B
$788K 0.02%
12,967
+3
+0% +$166
SO icon
237
Southern Company
SO
$109B
$780K 0.02%
12,547
+281
+2% +$16.8K
VO icon
238
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$778K 0.02%
14,056
-40
-0.3% -$2.17K
CABO icon
239
Cable One
CABO
$227M
$777K 0.02%
425
CBOE icon
240
Cboe Global Markets
CBOE
$32.5B
$774K 0.02%
7,847
TT icon
241
Trane Technologies
TT
$100B
$762K 0.02%
4,600
RJF icon
242
Raymond James Financial
RJF
$33.8B
$753K 0.02%
9,218
VEA icon
243
Vanguard FTSE Developed Markets ETF
VEA
$229B
$737K 0.02%
15,006
+1,625
+12% +$79.4K
VRTX icon
244
Vertex Pharmaceuticals
VRTX
$121B
$735K 0.02%
3,420
-35
-1% -$7.69K
TIP icon
245
iShares TIPS Bond ETF
TIP
$14.5B
$726K 0.02%
5,788
+300
+5% +$38K
VYM icon
246
Vanguard High Dividend Yield ETF
VYM
$80.9B
$723K 0.02%
7,149
BIL icon
247
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$719K 0.02%
7,855
-680
-8% -$62.2K
XYL icon
248
Xylem
XYL
$27.3B
$716K 0.02%
6,806
+3,500
+106% +$355K
AMAT icon
249
Applied Materials
AMAT
$403B
$708K 0.02%
5,296
+300
+6% +$33.1K
NSC icon
250
Norfolk Southern
NSC
$75.4B
$706K 0.02%
2,630
-4,287
-62% -$1.09M

Similar funds

Gofen & Glossberg's Q1 2021 Portfolio in Review

As of Q1 2021, Gofen & Glossberg held 576 positions worth $3.9B, up 6.9% from $3.65B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gofen & Glossberg's Q1 2021 filing shows 42 new, 208 increased, 140 reduced and 20 closed positions. Its largest new stake was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 284,378 shares worth $8.13M. The largest sale was DuPont de Nemours, an estimated $8.42M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q1 2021 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 284,378 shares worth $8.13M.
  • Gofen & Glossberg added most to Air Products & Chemicals in Q1 2021, an estimated $15.8M increase.
  • Gofen & Glossberg's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $8.42M.
  • Gofen & Glossberg fully exited Tiffany & Co. in Q1 2021, selling an estimated $2.36M.
  • Gofen & Glossberg's ten largest holdings make up 29% of its $3.9B portfolio in Q1 2021.
  • Gofen & Glossberg opened 42 new positions and closed 20 in Q1 2021.
  • Gofen & Glossberg's portfolio value rose 6.9% quarter-over-quarter to $3.9B.

Based on Gofen & Glossberg's 13F filing for Q1 2021, filed 13 Apr 2021.